home > news > detailed info

Michelle Shogren: The Importance of User Centricity in Times of Change for Clinical Trials

Marcus Evans Evolution Summit

Marcus evans Summits has announced Michelle Shogren, Senior Director of Innovation - Pharma R&D Clinical Operations at Bayer Pharmaceuticals, as a speaker at the upcoming 2020 Evolution Summit this March 2-4 at the Meritage Resort & Spa in Napa, CA.

The 21st Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.

The Summit is the perfect opportunity for leading industry executives to widen their peer network while sharpening their knowledge. Developed via a profound dialogue with key market players as well as extensive proprietary research, the event program will showcase over fifteen of the most sought after clinical trial & drug discovery leaders.

Shogren has over 20 years of experience in Clinical Research across many different roles. Beginning her journey as a research nurse and site director, she then took on the role of clinical research associate at a CRO, and finally joined Bayer Pharmaceuticals in 2008 where she has held multiple roles in including Clinical Operations, Training and Quality and her current position in Business Excellence and Innovation.

As the industry looks at new ways of working in clinical trials, it is important to think about who the end users will be and how these changes will affect them. Shogren’s session will address the importance of user centricity in these times of change for clinical trials. Questions on connecting to patients, collection of data and adding new technologies will be asked and new perspectives discussed, with a primary focus on the end users.

For more information on the summit, visit the website or contact
phone +35722849421
email The Meritage Resort & Spa, Napa, CA
Print this page
Send to a friend
News and Press Releases

Validation batches of the vaccine against equine strangles Strangvac® is completed

[Noáin, January 27, 2020] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics has, together with the Swedish biotechnology company Intervacc AB and LIOF-Pharma (previously Praxis Pharmaceutical), completed the manufacturing process for the vaccine against equine strangles called Strangvac®. The validation production batches required for the forthcoming registration application to the European Medicines Agency, EMA, are thus finalized.
More info >>

White Papers

The Use of Stainless Steel Equipment Within Laboratories and Clean Rooms

Teknomek Ltd

Teknomek explains why stainless steel is the material of choice for laboratories and hygienic manufacturing.
More info >>

Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement